Update shared on 18 Nov 2025
Fair value Increased 13%Analysts have raised their price target for Yatharth Hospital & Trauma Care Services from ₹835 to ₹940, citing improved revenue growth and stronger profit margins as key drivers behind the upward revision.
What's in the News
- A board meeting is scheduled for November 13, 2025, to consider and approve the unaudited financial results for the second quarter and half year ended September 30, 2025.
- The appointment of M/s. MSKA & Associates, a member firm of BDO International, as Statutory Auditor was confirmed at the AGM held on September 30, 2025, with remuneration fixed.
- A board meeting held on September 13, 2025, approved the proposal to acquire 100 percent interest in Shantived Institute of Medical Sciences at an enterprise value of INR 2,600 million.
Valuation Changes
- Consensus Analyst Price Target has increased from ₹835 to ₹940, indicating a notable upward revision.
- Discount Rate has risen marginally from 12.73% to 12.76%.
- Revenue Growth projection has increased slightly, moving from 33.07% to 33.85%.
- Net Profit Margin estimate has improved from 15.43% to 16.17%.
- Future P/E ratio has declined modestly from 41.92x to 41.29x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.